Yan Li

机构：Shanxi Academy of Medical Sciences, Nanjing Medical University · ORCID：0000-0001-5924-3961

发表论文 16 篇 · 总被引 230 次 · h-index 7

代表论文

• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 63)
• Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation (2025 · Frontiers in Immunology · 被引 53)
• Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas (2019 · International Journal of Clinical Oncology · 被引 32)
• Association of vitamin B1 with cardiovascular diseases, all-cause and cardiovascular mortality in US adults (2023 · Frontiers in Nutrition · 被引 21)
• Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer (2017 · Oncotarget · 被引 16)
• Risk factors associated with false negative rate of sentinel lymph node biopsy in endometrial cancer: a systematic review and meta-analysis (2024 · Frontiers in Oncology · 被引 13)